Clonal expansion of HIV-infected CD4+T-cells in patients on long-term ART was recently described by Maldarelli et. al. and Wagner et. al. (Science 2014), but the replication-competence of such proviruses is controversial. Cohn et. al. (Cell 2015) were unable to identify intact, clonally-expanded proviruses in vivo. Conversely, Simonetti et. al. (CROI 2015) described a case of persistent viremia during ART wherein the primary source was a clonally-expanded, replication-competent provirus. Here, we sought additional evidence of clonally-expanded, replication-competent proviruses in individuals on ART.
Viral outgrowth assays (VOAs) were performed on > 6×106 purified CD4+ T-cells from 8 consecutive participants who were on suppressive ART for > 2 years (median 13.5 years) and who had diverse virus populations consistent with long-term chronic infection prior to therapy. Purified CD4+ T-cells were seeded in six replicates of 3-fold serial dilutions beginning with 1×106 cells per well. Single-genome sequencing (SGS) targeting p6-PR-RT was performed on supernatants from p24 positive wells and on HIV cell-associated, unspliced HIV RNA (CAR) and HIV DNA (CAD) in PBMCs from the same individuals. Sequences were examined for matches across VOA wells and to PBMC CAR and CAD by neighbor-joining analyses.
In 6 of the 8 individuals studied to date, identical sequence matches have been found across multiple VOA positive wells or between VOA positive wells and CAR or CAD SGS. Replication-competent proviruses constituted a median of 1.3% (range 0.7-7.1%) of all unique viral variants and a median of 9.1% (range 7.7-20%) of all clonally-expanded variants detected by SGS.
We detected inducible, clonally-expanded, replication-competent proviruses in more than half of individuals studied on long-term suppressive ART. These expanded clones could serve as a persisting source for rebound viremia after interruption of ART and should be targeted by HIV cure strategies.